WHO Guideline: Summary of Recommendations on Pharmaceutical Pricing Policies

How will the new WHO recommendations on pharmaceutical pricing policies affect your organization?

Multimedia
Published on:
November 2, 2020

The WHO recently launched a series of recommendations on pharmaceutical pricing policies to help countries make medicines more affordable for the global population and lessen the burden on government budgets.

Alira Health’s Nerea Blanque-Catalina, VP, Market Access & Pricing, and Luis Culla, Associate Director, Global Market Access, dive into these new recommendations and provide advice on how companies can manage the impact of these new guidelines.

Report Download

Related news

Market Access
Multimedia January 19, 2022
Alira Health’s Transformation Talks: Early Access Programs: Why and How?
Listen to this episode of "Transformation Talks" to discover the benefits and challenges of implementing EAPs from both the industry and payer perspectives and the main recommendations(...)
M&A MedTech Pharma
News January 13, 2022
Alira Health Secures an Additional $40M in Funding, Led by Creadev
We announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. We intend to use the funds to invest in solutions that actively engage patients(...)
Pharma
Events December 23, 2021
Event: Presentation of the 2021 BioRegion Report
We are thrilled to announce that Alira Health has contributed to the BioRegion Report 2021,
Clinical Pharma
Publications December 21, 2021
An Insider Look at Vaccines: Yesterday, Today, Tomorrow
The COVID-19 pandemic has put vaccines in the spotlight. The pandemic has given the industry a considerable boost, and with lessons learned during the development and roll-out(...)
Market Access
Multimedia December 16, 2021
Alira Health’s Transformation Talks: Navigating the Vaccines’ Renaissance
Tune into this episode of "Transformation Talks" to learn more about the the ups and downs of the vaccine industry, how the COVID pandemic has transformed it, and what is coming up next. 
Advanced Analytics Digital Health Pharma Research & Development
Publications December 10, 2021
Leveraging Data Intelligence for Effective Opportunity Screening and Prioritization in Drug Discovery
Our biotech client needed an innovative, effective way to identify which binding sites and therapeutic indications they should target for the development of new therapeutic agents for(...)
Market Access
Publications December 3, 2021
White Paper: Enhancing Patient Access with Early Access Programs
Pharmaceutical companies are facing an increasing demand from physicians for Early Access Programs (EAPs) and are willing to make their innovative medicines available to patients with(...)
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.